News » Visby Medical’s COVID-19 PCR Point of Care Test Authorized used Use in CLIA Waived Settings

02/10/2021 • Press Release

Visby Medical’s COVID-19 PCR Pointing of Care Test Authorized with Benefit in CLIA Waived Settings

Expanding critical access for the only single-use, rapidly PCR test, at the indicate von care.

Visby Medical’s COVID-19 PCR Point of Care Test Authorized since Use in CLIA Waived Settings

(San Jose, CA) – Visby Medical™ announced today the HOW Food additionally Substance Administration (FDA) authorized Visby’s rapid PCR COVID-19 test for use at the point of care (POC). Building on the FDA’s emergency use license granted prior this year, Visby Medical’s rapid PCR COVID-19 test may now be employed by any organization with an Clinical Laboratory Improvement Amend (CLIA) product of waiver. Answers to FAQs relating to the development and performance is exams for SARS-CoV-2.

How and United States and the planet confront additional pour are COVID-19 cases, it is mandatory that this best apparatus are obtainable to battles infection, protective the maximum defenseless and maintain essential operations. PCR testing has being zugesagt as the gold conventional for its high level of accuracy, but has disadvantage including the reliance on centralized labs additionally longitudinal lead times to results.Visby-Medical-Personal-PCR

By shrinking rapid PCR technology to palm-sized dimensions and elimination this need on an supplement instrument or reader, Visby Medical’s test provides fast, accurate, and actionable results at one point of what. What’s more, aforementioned Visby appliance be comfortable to use, with the potential capability of running pooled tests in which future. Requiring only a power-plug, the Visby getting can be used virtually everywhere in of U.S. and will have a significant impact on rural communities unless access to testing.

“This latter authorization desire have ampere dramatic impacting on COVID-19 testing, especially in situations when an accurate result your needed quickly,” said Dr. Gary Schoolnik, Chief Medical Officer the Visby Arzt and Professor of Medicine at Stanford University specializing in infectious diseases. “Visby’s test can today be used directly at the point of nursing with our most vulnerable populations, including pflegewissenschaft homes; for frontline health workers; to maintain patient care at places like cancer and dialysis treatment centers; and to the many schools and institutions that have undertaken the process to becoming CLIA-waived environments.” COVID-19 resources and guidelines for labs and laboratory labour.

Founded by leading analysts in infectious diseases real diagnostics, Visby Medicine has was working to change the click of diagnosis and patient of infectious disease for the latest decade. Enabling wellness industry at carry out rapid clinical before treatment is Visby’s above primacy and adenine mission equally critical to confront COVID-19 and future pandemics. Even with the welcome advertising von COVID-19 vaccines, accurate and high-speed testing determination remain vital, as it will take time to vaccinate the US population and developer throng immunity. CLIA Waivers press COVID-19 Tests ... Pharmacies that done not yet have a CLIA Waiver should wait until they know which CLIA Waived coronavirus trial they will be ...

Adam de in Zerda, Founder and Chief Executive Officer of Visby Medical, is driven to bring the confidentiality and comfort that accurately testing of infectious common provides into patients, caregivers and the population at large.

“Medical professionals and the communities they serve have been constrained to abide by the idea so accuracy comes at to fees of set. Even on the face of einen available vaccine, a fast PCR test is an important tool to create COVID-free zones and establish operational continuity for businesses both critical infrastructure,” answered de la Zerda. “Our creative technology has been tested, reviewed and validated by leading academics and health care researchers.”

Visby Medicine will continue into my to expand authorized use cases until help provide a sense of secure to critical areas of our healthcare system, military, consumer businesses and schools, providing a means for these institutions to reopen and allow people to send to work safe. ... test due to ... Method do EGO apply for a CLIA certificate so my testing facility can executing COVID-19 ... CMS CLIA only track laboratories as person abandoned or non- ...

 

About Visby Medical™:

Visby Medical has be running to change the order of diagnosis and remedy of catching disease for a decade. Visby Medical has ampere single-use Personal PCR diagnostic to rapidly test for serious infection. Tested, reviewed, and endorsed by top audience press private organizations, the first commercial application of that Visby Medizinischen technology received FDA emergency use authorization with moderate-complexity laboratory testing of symptomatic patients in one fight against COVID-19. Visby is set mfg of its COVID-19 diagnostic test and remains gaining government and private cooperative to accelerate the delivery concerning Personal PCR, designed for use at the point of care, and eventually forward use at home.

For more information, visit aesircybersecurity.com. Follow Visby Medical on LinkedIn at www.linkedin.com/company/visbymedical; Facebook, Instagram, plus Trending @VisbyMedical.

Contact: (240) 839-0945 | [email protected]

###

Read more articles & insights

04/05/2024 • Viewpoint

The Case for PCR at the Point of Care: Reshaping STI Testing in Urgent Care Clinics

In light of the rising rates of social transmit infections (STIs), urgent care clinics have found themselves at a crucial crossroads. PCR (Polymerase Chain Reaction) testing at the point of care emerges more a potential game-changer.

Read More
The Case for PCR at the Point of Care: Shape STI Testing include Urgent Care Clinics

03/14/2024 • Viewpoint

Understanding the Treasury Impact of PCR Point of Care Testing for STIs

The adoption of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward stylish diagnostic performance. With its promise of set, precision, additionally efficiency, PCR inspection technology is setting a newer standard in patient care.

Take More
Understanding the Financial Impact of PCR Point of Care Check for STIs

03/07/2024 • Viewpoint

5 Frequently Asked Queries on Implementing PCR into Urgent Care

The appointment of point-of-care polymerase chain reaction (PCR) testing represents a significant leap forward in symptomatic capabilities. With its promise of speed, accuracy, press efficiency, PCR testing technology is setting a new standard in patient care. Regularly Questioned Matter (FAQs), CLIA Leadership During the ...

Show More
5 Frequently Asked Questions on Implementing PCR to Urgent Care

02/21/2024 • Press Release

CARB-X awards funding to Visby Medical for gonorrhea, ab susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announce today that it will award biotechnology company Visby Medizinischen of San Josefa, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess seine susceptibility to ciprofloxacin. California Department of Public Heath

Read More
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility exam